Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05224544 · ClinicalTrials.gov registry record · NA

Intermittent Catheterisation on the Bladder Mucosa of Healthy Volunteers With a Prototype Micro Hole Zone Catheter

A NA study, sponsored by Coloplast A/S.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT05224544 is a NA study that has completed, run by Coloplast A/S. The registered enrollment target is 43 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05224544, a NA study, has completed, sponsored by Coloplast A/S.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

This investigation is a randomized, single-blinded, parallel, single-center investigation. In total, up to 50 subjects (40 completers) were included and each subject had two test visits overseen by the Principal Investigator (PI), or designee. Each subject were enrolled in the investigation, which lasted up to 3 days (if Day 0 and Day 1 were not on same day). The subjects were randomly assigned to test either the prototype product or the comparator product, with at least 20 subjects assigned to each product.

Interventions

  • DEVICE Investigational prototype device
  • DEVICE Comparator device

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2022-01-31
Est. Completion 2022-03-31
Phase NA

Sponsor

Coloplast A/S

21 total trials

What the Registry Record Tells You About NCT05224544

The ClinicalTrials.gov registry entry for NCT05224544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Coloplast A/S, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Investigational prototype device is the first listed.

NCT05224544 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05224544 about?

NCT05224544 is a clinical study titled "Intermittent Catheterisation on the Bladder Mucosa of Healthy Volunteers With a Prototype Micro Hole Zone Catheter". This investigation is a randomized, single-blinded, parallel, single-center investigation. In total, up to 50 subjects (40 completers) were included and each subject had two test visits overseen by the Principal Investigator (PI), or designee. Each subject were enrolled in the investigation, which l...

What is the current status of trial NCT05224544?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2022-01-31. Estimated completion is 2022-03-31.

What interventions are being tested in trial NCT05224544?

The interventions under investigation include: Investigational prototype device (DEVICE), Comparator device (DEVICE).

Who is sponsoring clinical trial NCT05224544?

This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.